Quipt Home Medical (TSE:QIPT) Given New C$7.50 Price Target at Stifel Nicolaus

Quipt Home Medical (TSE:QIPTFree Report) had its price objective lowered by Stifel Nicolaus from C$8.40 to C$7.50 in a research report report published on Thursday morning,BayStreet.CA reports. Stifel Nicolaus currently has a buy rating on the stock.

Quipt Home Medical Price Performance

QIPT stock opened at C$3.56 on Thursday. The company has a market cap of C$153.40 million, a P/E ratio of -20.88 and a beta of 1.01. Quipt Home Medical has a 1 year low of C$3.28 and a 1 year high of C$6.98. The stock’s fifty day moving average price is C$3.72 and its 200-day moving average price is C$4.14.

Quipt Home Medical Company Profile

(Get Free Report)

Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment.

See Also

Receive News & Ratings for Quipt Home Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quipt Home Medical and related companies with MarketBeat.com's FREE daily email newsletter.